These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

898 related items for PubMed ID: 10824729

  • 1. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S, Gorini M, Salio M, Lucci D, Latini R, Maggioni AP.
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [Abstract] [Full Text] [Related]

  • 2. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [Abstract] [Full Text] [Related]

  • 3. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP, Lowes BD, Grayburn PA, White M, Krause-Steinrauf H, Krishnan V, Uyeda L, Burnett JC, BEST Neurohumoral Substudy Investigators.
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [Abstract] [Full Text] [Related]

  • 4. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM, Zaninotto M, Bacchiega E, Nalli C, Forni M, Tiso E, Cacciavillani L, Razzolini R, Plebani M.
    Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
    [Abstract] [Full Text] [Related]

  • 5. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL, Robert A, Ahn S, van Linden F, Ketelslegers JM, Pouleur H, Rousseau MF.
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [Abstract] [Full Text] [Related]

  • 6. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T, Kato M, Ogino K, Osaki S, Igawa O, Hisatome I, Shigemasa C.
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [Abstract] [Full Text] [Related]

  • 7. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.
    Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508
    [Abstract] [Full Text] [Related]

  • 8. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S, Giovinazzo P, Noventa F, Valle R.
    J Card Fail; 2008 Jun 15; 14(5):420-5. PubMed ID: 18514935
    [Abstract] [Full Text] [Related]

  • 9. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Kinoshita M.
    J Card Fail; 2001 Dec 15; 7(4):322-8. PubMed ID: 11782855
    [Abstract] [Full Text] [Related]

  • 10. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
    Berger R, Huelsmann M, Strecker K, Moertl D, Moser P, Bojic A, Pacher R.
    Eur J Clin Invest; 2005 Jan 15; 35(1):24-31. PubMed ID: 15638816
    [Abstract] [Full Text] [Related]

  • 11. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB, O'Brien RJ, Demme B, Davies JE, Ng LL.
    Clin Sci (Lond); 2004 Sep 15; 107(3):309-16. PubMed ID: 15182235
    [Abstract] [Full Text] [Related]

  • 12. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.
    Bentzen H, Pedersen RS, Pedersen HB, Nyvad O, Pedersen EB.
    Clin Sci (Lond); 2003 Mar 15; 104(3):303-12. PubMed ID: 12605591
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.
    Gwechenberger M, Hülsmann M, Berger R, Graf S, Springer C, Stanek B, Pacher R.
    J Heart Lung Transplant; 2004 Jul 15; 23(7):839-44. PubMed ID: 15261178
    [Abstract] [Full Text] [Related]

  • 14. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M, Van Gelder IC, Van den Berg MP, Boomsma F, Van Veldhuisen DJ.
    Europace; 2006 Jul 15; 8(7):482-7. PubMed ID: 16798760
    [Abstract] [Full Text] [Related]

  • 15. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.
    Hülsmann M, Berger R, Sturm B, Bojic A, Woloszczuk W, Bergler-Klein J, Pacher R.
    Eur Heart J; 2002 Jun 15; 23(11):886-91. PubMed ID: 12042010
    [Abstract] [Full Text] [Related]

  • 16. Natriuretic peptides in patients with atrial fibrillation.
    Wozakowska-Kapłon B, Opolski G, Herman Z, Kosior D.
    Cardiol J; 2008 Jun 15; 15(6):525-9. PubMed ID: 19039756
    [Abstract] [Full Text] [Related]

  • 17. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
    Yeh JL, Hsu JH, Dai ZK, Liou SF, Chen IJ, Wu JR.
    Int J Cardiol; 2005 Sep 15; 104(1):15-20. PubMed ID: 16055212
    [Abstract] [Full Text] [Related]

  • 18. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 19. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure.
    Wozakowska-Kapłon B, Opolski G, Janion M, Kosior D.
    Kardiol Pol; 2004 Dec 22; 61(12):513-21; discussion 522. PubMed ID: 15815752
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.